首页 > 最新文献

Gynecologie Obstetrique Fertilite & Senologie最新文献

英文 中文
Sommaire 目录
IF 0.8 4区 医学 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2024-06-01 DOI: 10.1016/S2468-7189(24)00217-4
{"title":"Sommaire","authors":"","doi":"10.1016/S2468-7189(24)00217-4","DOIUrl":"https://doi.org/10.1016/S2468-7189(24)00217-4","url":null,"abstract":"","PeriodicalId":56056,"journal":{"name":"Gynecologie Obstetrique Fertilite & Senologie","volume":"52 6","pages":"Pages v-vi"},"PeriodicalIF":0.8,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2468718924002174/pdfft?md5=fa4abf9e7d2b4f299b01a5948332de15&pid=1-s2.0-S2468718924002174-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141294588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sentilhes L, Sénat M.V, Bouchghoul H, Delorme P, Gallot D, Garabedian C, Madar H, Sananès N, Perrotin F, Schmitz T. Réponse à l’article de Boujenah J. intitulé « La cholestase gravidique : pour une vision holistique de la femme. À propos des examens complémentaires lors du diagnostic ». Gynecol Obstet Fertil 2024;52(6). doi:10.1016/j.gofs.2024.02.023 [L.Senthiles、M.V Sénat、H.Bouchghoul、P.Delorme、D.Gallot、Ch Garabedian、H.Madar、N.Sananès、F.Perrotin、T.Schmitz 对 J.Boujenah 题为 "La cholestase gravidique: pour une vision holistique de la femme.À propos des examens complémentaires lors du diagnostic".Gynecol Obstet Fertil 2024; 52(6).10.1016/j.gofs.2024.02.023].
IF 0.8 4区 医学 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2024-06-01 DOI: 10.1016/j.gofs.2024.02.024
Loïc Sentilhes , Marie-Victoire Sénat , Hanane Bouchghoul , Pierre Delorme , Denis Gallot , Charles Garabedian , Hugo Madar , Nicolas Sananès , Franck Perrotin , Thomas Schmitz
{"title":"Sentilhes L, Sénat M.V, Bouchghoul H, Delorme P, Gallot D, Garabedian C, Madar H, Sananès N, Perrotin F, Schmitz T. Réponse à l’article de Boujenah J. intitulé « La cholestase gravidique : pour une vision holistique de la femme. À propos des examens complémentaires lors du diagnostic ». Gynecol Obstet Fertil 2024;52(6). doi:10.1016/j.gofs.2024.02.023","authors":"Loïc Sentilhes , Marie-Victoire Sénat , Hanane Bouchghoul , Pierre Delorme , Denis Gallot , Charles Garabedian , Hugo Madar , Nicolas Sananès , Franck Perrotin , Thomas Schmitz","doi":"10.1016/j.gofs.2024.02.024","DOIUrl":"10.1016/j.gofs.2024.02.024","url":null,"abstract":"","PeriodicalId":56056,"journal":{"name":"Gynecologie Obstetrique Fertilite & Senologie","volume":"52 6","pages":"Pages 440-441"},"PeriodicalIF":0.8,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139974757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Devenir obstétrical des patientes transplantées rénales suivies dans une maternité de type III. Étude rétrospective de 2000 à 2020 一家三甲妇产医院随访的肾移植患者的产科结果。2000年至2020年的回顾性研究
IF 0.8 4区 医学 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2024-06-01 DOI: 10.1016/j.gofs.2024.01.011
Aurélie Reitz , Marion Rouzaire , Romain Cahierc , Bruno Pereira , Richard Lemal , Cyril Garrouste , Denis Gallot

Aim

To describe pregnancy outcome of kidney transplant patients till 1 year postpartum.

Methods

This retrospective, monocentric study included 15 kidney transplant patients who presented 18 pregnancies, between January 2000 and January 2020. For each of them, we searched for possible obstetrical, fetal and renal complications and we evaluated renal function before, during and after pregnancy.

Results

The live birth rate was 84% (16/19) with an average gestational age at delivery of 37 weeks of gestation. The rate of prematurity was 50% (8/16), gestational diabetes was 16.6% (3/18) and preeclampsia was 27.7% (5/18). Cesarean section was performed in 61.1% (11/18) of cases including, 81.8% (9/11) unplanned surgery. The average birth weight was 2635 grams and 37.5% (6/16) of the newborn were small for gestational age. All patients had stable renal function before conception of pregnancy. We noticed two acute graft rejection during pregnancy with only one resulting in graft loss. Four patients had a reduced graft function in 12 months of the postpartum.

Conclusion

Risk of maternal, fetal and renal complications remained high in kidney transplant recipients. Pregnancy should be carefully planned in transplanted women associated with adequate follow-up according to clinical guidelines (normal renal function and blood pressure without proteinuria before pregnancy, no recent graft rejection, period of one year after transplant respected and no teratogenic treatment in the month before pregnancy).

目的描述肾移植患者产后 1 年的妊娠结局。方法这项回顾性、单中心研究纳入了 2000 年 1 月至 2020 年 1 月期间妊娠 18 次的 15 名肾移植患者。结果 活产率为 84%(16/19),平均孕周为 37 周。早产率为 50%(8/16),妊娠糖尿病为 16.6%(3/18),子痫前期为 27.7%(5/18)。61.1%(11/18)的病例实施了剖宫产手术,其中81.8%(9/11)为计划外手术。新生儿平均体重为 2635 克,37.5%(6/16)的新生儿胎龄较小。所有患者在怀孕前肾功能都很稳定。我们注意到有两名患者在怀孕期间出现急性移植物排斥反应,其中只有一人导致移植物丢失。结论肾移植受者发生母体、胎儿和肾脏并发症的风险仍然很高。根据临床指南(妊娠前肾功能和血压正常且无蛋白尿、近期无移植物排斥反应、移植后一年内受到尊重、妊娠前一个月内未接受致畸治疗),接受肾移植的妇女应谨慎计划妊娠,并进行充分的随访。
{"title":"Devenir obstétrical des patientes transplantées rénales suivies dans une maternité de type III. Étude rétrospective de 2000 à 2020","authors":"Aurélie Reitz ,&nbsp;Marion Rouzaire ,&nbsp;Romain Cahierc ,&nbsp;Bruno Pereira ,&nbsp;Richard Lemal ,&nbsp;Cyril Garrouste ,&nbsp;Denis Gallot","doi":"10.1016/j.gofs.2024.01.011","DOIUrl":"10.1016/j.gofs.2024.01.011","url":null,"abstract":"<div><h3>Aim</h3><p>To describe pregnancy outcome of kidney transplant patients till 1 year postpartum.</p></div><div><h3>Methods</h3><p>This retrospective, monocentric study included 15 kidney transplant patients who presented 18 pregnancies, between January 2000 and January 2020. For each of them, we searched for possible obstetrical, fetal and renal complications and we evaluated renal function before, during and after pregnancy.</p></div><div><h3>Results</h3><p>The live birth rate was 84% (16/19) with an average gestational age at delivery of 37 weeks of gestation. The rate of prematurity was 50% (8/16), gestational diabetes was 16.6% (3/18) and preeclampsia was 27.7% (5/18). Cesarean section was performed in 61.1% (11/18) of cases including, 81.8% (9/11) unplanned surgery. The average birth weight was 2635 grams and 37.5% (6/16) of the newborn were small for gestational age. All patients had stable renal function before conception of pregnancy. We noticed two acute graft rejection during pregnancy with only one resulting in graft loss. Four patients had a reduced graft function in 12<!--> <!-->months of the postpartum.</p></div><div><h3>Conclusion</h3><p>Risk of maternal, fetal and renal complications remained high in kidney transplant recipients. Pregnancy should be carefully planned in transplanted women associated with adequate follow-up according to clinical guidelines (normal renal function and blood pressure without proteinuria before pregnancy, no recent graft rejection, period of one year after transplant respected and no teratogenic treatment in the month before pregnancy).</p></div>","PeriodicalId":56056,"journal":{"name":"Gynecologie Obstetrique Fertilite & Senologie","volume":"52 6","pages":"Pages 391-397"},"PeriodicalIF":0.8,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139687813","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment Palmer faisait… Raoul Palmer et l’aventure de la cœliochirurgie [帕尔默是如何做到的......拉乌尔-帕尔默和腹腔镜奥德赛]。
IF 0.8 4区 医学 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2024-06-01 DOI: 10.1016/j.gofs.2024.02.004
Patrick Madelenat , Gautier Chene
{"title":"Comment Palmer faisait… Raoul Palmer et l’aventure de la cœliochirurgie","authors":"Patrick Madelenat ,&nbsp;Gautier Chene","doi":"10.1016/j.gofs.2024.02.004","DOIUrl":"10.1016/j.gofs.2024.02.004","url":null,"abstract":"","PeriodicalId":56056,"journal":{"name":"Gynecologie Obstetrique Fertilite & Senologie","volume":"52 6","pages":"Pages 428-431"},"PeriodicalIF":0.8,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139718096","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment je fais… Optimiser mes réglages Doppler pour une analyse du cœur fœtal au premier trimestre de la grossesse ? 如何...... 优化多普勒设置,以便在怀孕前三个月进行胎心分析?
IF 0.6 4区 医学 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2024-05-24 DOI: 10.1016/j.gofs.2024.05.002
Maud Allary , Edwin Quarello
{"title":"Comment je fais… Optimiser mes réglages Doppler pour une analyse du cœur fœtal au premier trimestre de la grossesse ?","authors":"Maud Allary ,&nbsp;Edwin Quarello","doi":"10.1016/j.gofs.2024.05.002","DOIUrl":"10.1016/j.gofs.2024.05.002","url":null,"abstract":"","PeriodicalId":56056,"journal":{"name":"Gynecologie Obstetrique Fertilite & Senologie","volume":"52 12","pages":"Pages 720-724"},"PeriodicalIF":0.6,"publicationDate":"2024-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141131520","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Faut-il dépister un vasa prævia ? 有必要筛查前置胎盘吗?
IF 0.6 4区 医学 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2024-05-23 DOI: 10.1016/j.gofs.2024.05.001
Jeremy Boujenah , Celine Dupont-Bernabe , Claire Thuillier , Nicolas Sananes , Philippe Bouhanna , Patrick Rozenberg
{"title":"Faut-il dépister un vasa prævia ?","authors":"Jeremy Boujenah ,&nbsp;Celine Dupont-Bernabe ,&nbsp;Claire Thuillier ,&nbsp;Nicolas Sananes ,&nbsp;Philippe Bouhanna ,&nbsp;Patrick Rozenberg","doi":"10.1016/j.gofs.2024.05.001","DOIUrl":"10.1016/j.gofs.2024.05.001","url":null,"abstract":"","PeriodicalId":56056,"journal":{"name":"Gynecologie Obstetrique Fertilite & Senologie","volume":"52 12","pages":"Pages 732-736"},"PeriodicalIF":0.6,"publicationDate":"2024-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141141795","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
L’hyperparathyroïdie primaire durant la grossesse : étude d’un cas [妊娠期原发性甲状旁腺功能亢进症:病例报告]。
IF 0.6 4区 医学 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2024-05-09 DOI: 10.1016/j.gofs.2024.04.005
Jonathan Sabah , Alexis Marouk , Eric Boudier , Gilles-Davy Kossa-Ko-Ouakoua , Philippe Deruelle
{"title":"L’hyperparathyroïdie primaire durant la grossesse : étude d’un cas","authors":"Jonathan Sabah ,&nbsp;Alexis Marouk ,&nbsp;Eric Boudier ,&nbsp;Gilles-Davy Kossa-Ko-Ouakoua ,&nbsp;Philippe Deruelle","doi":"10.1016/j.gofs.2024.04.005","DOIUrl":"10.1016/j.gofs.2024.04.005","url":null,"abstract":"","PeriodicalId":56056,"journal":{"name":"Gynecologie Obstetrique Fertilite & Senologie","volume":"52 12","pages":"Pages 730-731"},"PeriodicalIF":0.6,"publicationDate":"2024-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140909645","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact du mode de suivi des ruptures prématurées des membranes avant 36 SA sur la durée de latence [妊娠36周前胎膜早破的随访方式对潜伏期的影响]。
IF 0.6 4区 医学 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2024-05-09 DOI: 10.1016/j.gofs.2024.04.006
Charlotte Le Lann , Élodie Drumez , Louise Ghesquiere , Norbert Winer , Vincent Dochez , Émilie Misbert

Introduction

Preterm premature rupture of membranes (PPROM) is the main cause of premature delivery, complicating 1–3% of all pregnancies. Conventional hospitalization (CH) is the most frequent mode of follow-up, but homecare (HC) seems to be an alternative.

Objectives

Study of the impact of the monitoring mode on the duration of the latency period and on the latency ratio after PPROM, and analysis of the risk factors modifying this ratio.

Methods

This was a bicentric retrospective cohort study here-abouts including patients who presented a PPROM between 24 and 36 weeks of gestation from 2016 to 2018. Patients had a follow-up in HC at Lille University Hospital center (UHC) and in CH at Nantes UHC according to two different follow-up protocols. The latency ratio corresponded to the real latency period divided by the latency period to theoretical term.

Results

We included 154 patients: 102 in HC and 52 in CH. The mean latency period was significantly higher in HC: 36.9 ± 21.8 days, corresponding to an 85.5 ± 23.7% latency ratio versus 20.2 ± 12 days, corresponding to an 66.9 ± 29.8% latency ratio in CH (P < 0.001). The latency ratio in CH was correlated with term at PPROM (P = 0.001).

Conclusions

The duration of the latency period seems prolonged for PPROM followed by HC management versus CH in selected populations. This study suggests a benefit to HC in stable patients.
导言早产胎膜早破(PPROM)是导致早产的主要原因,1%-3%的孕妇会因此并发早产。传统的住院治疗(CH)是最常见的随访方式,但家庭护理(HC)似乎是另一种选择:研究监测模式对早产后潜伏期持续时间和潜伏期比率的影响,并分析改变这一比率的风险因素:这是一项双中心回顾性队列研究,包括2016年至2018年妊娠24周至36周期间出现PPROM的患者。根据两种不同的随访方案,患者分别在里尔大学医院中心(UHC)的HC和南特大学医院中心(UHC)的CH接受随访。潜伏期比率相当于实际潜伏期除以理论足月潜伏期:我们共纳入了154名患者:102名HC患者和52名CH患者。HC患者的平均潜伏期明显更高:36.9±21.8天,潜伏期比率为85.5±23.7%;CH患者的平均潜伏期为20.2±12天,潜伏期比率为66.9±29.8%(P< 0.001)。结论:结论:在特定人群中,PPROM 后进行 HC 管理与 CH 相比,潜伏期的持续时间似乎更长。这项研究表明,在病情稳定的患者中使用 HC 有好处。
{"title":"Impact du mode de suivi des ruptures prématurées des membranes avant 36 SA sur la durée de latence","authors":"Charlotte Le Lann ,&nbsp;Élodie Drumez ,&nbsp;Louise Ghesquiere ,&nbsp;Norbert Winer ,&nbsp;Vincent Dochez ,&nbsp;Émilie Misbert","doi":"10.1016/j.gofs.2024.04.006","DOIUrl":"10.1016/j.gofs.2024.04.006","url":null,"abstract":"<div><h3>Introduction</h3><div>Preterm premature rupture of membranes (PPROM) is the main cause of premature delivery, complicating 1–3% of all pregnancies. Conventional hospitalization (CH) is the most frequent mode of follow-up, but homecare (HC) seems to be an alternative.</div></div><div><h3>Objectives</h3><div>Study of the impact of the monitoring mode on the duration of the latency period and on the latency ratio after PPROM, and analysis of the risk factors modifying this ratio.</div></div><div><h3>Methods</h3><div>This was a bicentric retrospective cohort study here-abouts including patients who presented a PPROM between 24 and 36<!--> <!-->weeks of gestation from 2016 to 2018. Patients had a follow-up in HC at Lille University Hospital center (UHC) and in CH at Nantes UHC according to two different follow-up protocols. The latency ratio corresponded to the real latency period divided by the latency period to theoretical term.</div></div><div><h3>Results</h3><div>We included 154 patients: 102 in HC and 52 in CH. The mean latency period was significantly higher in HC: 36.9<!--> <!-->±<!--> <!-->21.8 days, corresponding to an 85.5<!--> <!-->±<!--> <!-->23.7% latency ratio versus 20.2<!--> <!-->±<!--> <!-->12 days, corresponding to an 66.9<!--> <!-->±<!--> <!-->29.8% latency ratio in CH (<em>P</em> <!-->&lt;<!--> <!-->0.001). The latency ratio in CH was correlated with term at PPROM (<em>P</em> <!-->=<!--> <!-->0.001).</div></div><div><h3>Conclusions</h3><div>The duration of the latency period seems prolonged for PPROM followed by HC management versus CH in selected populations. This study suggests a benefit to HC in stable patients.</div></div>","PeriodicalId":56056,"journal":{"name":"Gynecologie Obstetrique Fertilite & Senologie","volume":"52 12","pages":"Pages 677-682"},"PeriodicalIF":0.6,"publicationDate":"2024-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140909644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prise en charge de première intention du couple infertile : mise à jour des RPC 2010 du CNGOF [不孕夫妇的一线治疗。法国妇产科医师学会临床实践指南 2022]。
IF 0.8 4区 医学 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2024-05-01 DOI: 10.1016/j.gofs.2024.01.014
Charlotte Sonigo , Geoffroy Robin , Florence Boitrelle , Eloïse Fraison , Nathalie Sermondade , Emmanuelle Mathieu d’Argent , Pierre-Emmanuel Bouet , Charlotte Dupont , Hélène Creux , Maeliss Peigné , Olivier Pirrello , Sabine Trombert , Emmanuel Lecorche , Ludivine Dion , Laurence Rocher , Emmanuel Arama , Valérie Bernard , Margaux Monnet , Laura Miquel , Eva Birsal , Blandine Courbiere
<div><h3>Objective</h3><p>To update the 2010 CNGOF clinical practice guidelines for the first-line management of infertile couples.</p></div><div><h3>Materials and methods</h3><p>Five major themes (first-line assessment of the infertile woman, first-line assessment of the infertile man, prevention of exposure to environmental factors, initial management using ovulation induction regimens, first-line reproductive surgery) were identified, enabling 28 questions to be formulated using the Patients, Intervention, Comparison, Outcome (PICO) format. Each question was addressed by a working group that had carried out a systematic review of the literature since 2010, and followed the Grading of Recommendations Assessment, Development and Evaluation (GRADE®) methodology to assess the quality of the scientific data on which the recommendations were based. These recommendations were then validated during a national review by 40 national experts.</p></div><div><h3>Results</h3><p>The fertility work-up is recommended to be prescribed according to the woman's age: after one year of infertility before the age of 35 and after 6<!--> <!-->months after the age of 35. A couple's initial infertility work-up includes a single 3D ultrasound scan with antral follicle count, assessment of tubal permeability by hysterography or HyFOSy, anti-Mullerian hormone assay prior to assisted reproduction, and vaginal swabbing for vaginosis. If the 3D ultrasound is normal, hysterosonography and diagnostic hysteroscopy are not recommended as first-line procedures. <em>Chlamydia trachomatis</em> serology does not have the necessary performance to predict tubal patency. Post-coital testing is no longer recommended. In men, spermogram, spermocytogram and spermoculture are recommended as first-line tests. If the spermogram is normal, it is not recommended to check the spermogram. If the spermogram is abnormal, an examination by an andrologist, an ultrasound scan of the testicles and hormonal test are recommended. Based on the data in the literature, we are unable to recommend a BMI threshold for women that would contraindicate medical management of infertility. A well-balanced Mediterranean-style diet, physical activity and the cessation of smoking and cannabis are recommended for infertile couples. For fertility concern, it is recommended to limit alcohol consumption to less than 5 glasses a week. If the infertility work-up reveals no abnormalities, ovulation induction is not recommended for normo-ovulatory women. If intrauterine insemination is indicated based on an abnormal infertility work-up, gonadotropin stimulation and ovulation monitoring are recommended to avoid multiple pregnancies. If the infertility work-up reveals no abnormality, laparoscopy is probably recommended before the age of 30 to increase natural pregnancy rates. In the case of hydrosalpinx, surgical management is recommended prior to ART, with either salpingotomy or salpingectomy depending on the tubal score. It is
目的:更新2010年CNGOF不孕不育夫妇一线治疗临床实践指南:更新2010年CNGOF不孕夫妇一线治疗临床实践指南:确定了五大主题(不孕女性的一线评估、不孕男性的一线评估、环境因素暴露的预防、使用促排卵方案的初始管理、一线生殖手术),并采用 PICO(患者、干预、比较、结果)格式制定了 28 个问题。自 2010 年以来,工作组对文献进行了系统性审查,并采用 GRADE®(建议的评估、制定和评价分级)方法对建议所依据的科学数据的质量进行了评估。随后,40 位国内专家对这些建议进行了全国性评审:结果:建议根据妇女的年龄进行不孕症检查:35 岁前不孕一年后和 35 岁后不孕 6 个月后。一对夫妇最初的不孕症检查包括一次三维超声波扫描和前卵泡计数、通过子宫造影或 HyFOSy 评估输卵管通畅性、辅助生殖前抗穆勒氏管激素测定以及阴道拭子检查阴道炎。如果三维超声检查结果正常,则不建议将子宫输卵管造影术和诊断性宫腔镜检查作为一线程序。沙眼衣原体血清学检测不具备预测输卵管通畅性的必要性能。不再建议进行性交后检测。对于男性,建议将精子图、精子细胞图和精子培养作为一线检查。如果精子图正常,则不建议检查精子图。如果精子图异常,建议由睾丸科医生进行检查、睾丸超声波扫描和激素检测。根据文献中的数据,我们无法推荐女性体重指数(BMI)的临界值,因此不建议对不孕不育症进行医学治疗。 建议不孕不育夫妇摄入均衡的地中海式饮食、进行体育锻炼、戒烟戒大麻。出于对生育的考虑,建议每周饮酒少于 5 杯。如果不孕症检查未发现异常,不建议对正常排卵的女性进行促排卵。如果根据不孕症检查结果显示异常,需要进行宫腔内人工授精,建议进行促性腺激素刺激和排卵监测,以避免多胎妊娠。如果不孕症检查未发现异常,可能建议在 30 岁之前进行腹腔镜检查,以提高自然怀孕率。如果是输卵管积水,建议在人工受精前进行手术治疗,根据输卵管评分选择输卵管切开术或输卵管切除术。建议在抗逆转录病毒疗法前对大于 10 毫米的息肉、0、1、2 号肌瘤和鞘膜积液进行手术。根据文献数据,我们无法系统地建议将无症状的子宫纵隔和子宫峡部作为一线手术:基于专家之间的强烈共识,我们能够在 28 个领域制定出有关不孕夫妇初期管理的最新建议。
{"title":"Prise en charge de première intention du couple infertile : mise à jour des RPC 2010 du CNGOF","authors":"Charlotte Sonigo ,&nbsp;Geoffroy Robin ,&nbsp;Florence Boitrelle ,&nbsp;Eloïse Fraison ,&nbsp;Nathalie Sermondade ,&nbsp;Emmanuelle Mathieu d’Argent ,&nbsp;Pierre-Emmanuel Bouet ,&nbsp;Charlotte Dupont ,&nbsp;Hélène Creux ,&nbsp;Maeliss Peigné ,&nbsp;Olivier Pirrello ,&nbsp;Sabine Trombert ,&nbsp;Emmanuel Lecorche ,&nbsp;Ludivine Dion ,&nbsp;Laurence Rocher ,&nbsp;Emmanuel Arama ,&nbsp;Valérie Bernard ,&nbsp;Margaux Monnet ,&nbsp;Laura Miquel ,&nbsp;Eva Birsal ,&nbsp;Blandine Courbiere","doi":"10.1016/j.gofs.2024.01.014","DOIUrl":"10.1016/j.gofs.2024.01.014","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Objective&lt;/h3&gt;&lt;p&gt;To update the 2010 CNGOF clinical practice guidelines for the first-line management of infertile couples.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Materials and methods&lt;/h3&gt;&lt;p&gt;Five major themes (first-line assessment of the infertile woman, first-line assessment of the infertile man, prevention of exposure to environmental factors, initial management using ovulation induction regimens, first-line reproductive surgery) were identified, enabling 28 questions to be formulated using the Patients, Intervention, Comparison, Outcome (PICO) format. Each question was addressed by a working group that had carried out a systematic review of the literature since 2010, and followed the Grading of Recommendations Assessment, Development and Evaluation (GRADE®) methodology to assess the quality of the scientific data on which the recommendations were based. These recommendations were then validated during a national review by 40 national experts.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;p&gt;The fertility work-up is recommended to be prescribed according to the woman's age: after one year of infertility before the age of 35 and after 6&lt;!--&gt; &lt;!--&gt;months after the age of 35. A couple's initial infertility work-up includes a single 3D ultrasound scan with antral follicle count, assessment of tubal permeability by hysterography or HyFOSy, anti-Mullerian hormone assay prior to assisted reproduction, and vaginal swabbing for vaginosis. If the 3D ultrasound is normal, hysterosonography and diagnostic hysteroscopy are not recommended as first-line procedures. &lt;em&gt;Chlamydia trachomatis&lt;/em&gt; serology does not have the necessary performance to predict tubal patency. Post-coital testing is no longer recommended. In men, spermogram, spermocytogram and spermoculture are recommended as first-line tests. If the spermogram is normal, it is not recommended to check the spermogram. If the spermogram is abnormal, an examination by an andrologist, an ultrasound scan of the testicles and hormonal test are recommended. Based on the data in the literature, we are unable to recommend a BMI threshold for women that would contraindicate medical management of infertility. A well-balanced Mediterranean-style diet, physical activity and the cessation of smoking and cannabis are recommended for infertile couples. For fertility concern, it is recommended to limit alcohol consumption to less than 5 glasses a week. If the infertility work-up reveals no abnormalities, ovulation induction is not recommended for normo-ovulatory women. If intrauterine insemination is indicated based on an abnormal infertility work-up, gonadotropin stimulation and ovulation monitoring are recommended to avoid multiple pregnancies. If the infertility work-up reveals no abnormality, laparoscopy is probably recommended before the age of 30 to increase natural pregnancy rates. In the case of hydrosalpinx, surgical management is recommended prior to ART, with either salpingotomy or salpingectomy depending on the tubal score. It is","PeriodicalId":56056,"journal":{"name":"Gynecologie Obstetrique Fertilite & Senologie","volume":"52 5","pages":"Pages 305-335"},"PeriodicalIF":0.8,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2468718924000370/pdfft?md5=c4d64ad6a22756c6c3b0a798d6d3ea8a&pid=1-s2.0-S2468718924000370-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139708665","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Peut-on réduire la durée du tamponnement intra-utérin par ballonnet ? Analyse secondaire d’un essai randomisé 宫内球囊填塞的持续时间可以缩短吗?随机试验的二次分析
IF 0.8 4区 医学 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2024-05-01 DOI: 10.1016/j.gofs.2024.03.051
C. Prats , C. Garabedian , P. Rozenberg , P. Berveiller
<div><h3>Contexte</h3><p>Le recours au ballon de tamponnement intra-utérin (BTIU) dans la prise en charge de l’hémorragie du post-partum immédiate (HPPI), après échec des traitements utérotoniques, fait partie des algorithmes de prise en charge. Les facteurs prédictifs d’échec avant l’insertion du BTIU sont bien connus, de même que l’importance pronostique des premières minutes après la mise en place du ballon. Après contrôle de l’hémorragie par le BTIU, des questions subsistent quant à la durée appropriée de tamponnement par ballon.</p></div><div><h3>Objectif</h3><p>Évaluer l’impact de la réduction de la durée du BTIU sur le risque de récidive de l’hémorragie.</p></div><div><h3>Méthode</h3><p>Il s’agit d’une analyse secondaire non planifiée de l’essai multicentrique TUB (essai validé par le CPP de Poissy, consentement écrit des patientes), qui évaluait l’efficacité d’un BTIU précoce sur l’HPPI après un accouchement par voie vaginale. Dans notre étude, seules les femmes prises en charge par un BTIU ont été incluses. Les femmes dont le ballon a été retiré dans les deux premières heures suivant sa mise en place et les femmes ayant eu une procédure invasive avant le retrait du BTIU ont été exclues. Les critères de jugement ont été : la survenue d’une procédure invasive après le retrait du ballon, les pertes sanguines totales, les transfusions de culots globulaires, ainsi que l’endométrite du postpartum, l’allaitement à la sortie de l’hôpital et la durée du séjour à l’hôpital. Le premier quartile pour la durée totale du BTIU dans notre population étant de 6,9<!--> <!-->heures, les patientes qui ont eu un BTIU pendant ≤<!--> <!-->7<!--> <!-->heures ont été comparées à celles qui ont eu un BTIU pendant<!--> <!-->><!--> <!-->7<!--> <!-->heures.</p></div><div><h3>Résultats</h3><p>199 patientes ont été incluses, dont 51 ont eu un BTIU pendant moins de 7<!--> <!-->heures. Il n’y avait pas de différence significative entre les deux groupes sur les caractéristiques maternelles, l’accouchement et la prise en charge de l’HPPI. Il n’y a eu aucun recours à une procédure invasive après le retrait du ballon dans les deux groupes. Il n’y avait pas de différence significative en ce qui concerne les pertes sanguines totales quantifiées (BTIU ≤ 7<!--> <!-->h : 1126<!--> <!-->mL (383) vs BTIU<!--> <!-->><!--> <!-->7<!--> <!-->h : 1240<!--> <!-->mL (505), <em>p</em> <!-->=<!--> <!-->0,1) ou la transfusion de CGR (BTIU<!--> <!-->≤<!--> <!-->7<!--> <!-->h : 9 (18 %) vs BTIU<!--> <!-->><!--> <!-->7<!--> <!-->h : 40 (27 %), <em>p</em> <!-->=<!--> <!-->0,2). Concernant le postpartum, aucune différence significative n’était observée sur la survenue d’une endométrite 6 semaines après l’accouchement (BTIU<!--> <!-->≤<!--> <!-->7<!--> <!-->h : 1 (2 %) vs BTUI<!--> <!-->><!--> <!-->7<!--> <!-->h : 2 (2 %), <em>p</em> <!-->=<!--> <!-->0,9), l’allaitement à la sortie (BTIU ≤<!--> <!-->7<!--> <!-->h : 40 (78 %) vs BTIU<!--> <!-->><!--> <!-->7<!--> <!-->h : 104 (70 %),
背景在子宫收缩治疗失败后,使用宫腔内填塞球囊(IUBB)治疗产后即刻出血(IPPH)是治疗算法的一部分。插入 IUPB 前预测失败的因素众所周知,而插入球囊后最初几分钟的预后重要性也是众所周知。目的评估缩短IUCB持续时间对复发性出血风险的影响。该试验评估了早期 IUTB 对阴道分娩后 IPH 的疗效。在我们的研究中,只纳入了使用 IUCB 的产妇。不包括在插入后两小时内取出球囊的产妇以及在取出 IUCB 之前接受过侵入性手术的产妇。结果测量指标包括:球囊取出后侵入性手术的发生率、总失血量、包装红细胞输血量以及产后子宫内膜炎、出院时的母乳喂养情况和住院时间。由于我国人口中 IUTI 总持续时间的第一四分位数为 6.9 小时,因此将 IUTI 持续时间少于 7 小时的患者与 IUTI 持续时间为 > 7 小时的患者进行了比较。两组患者在产妇特征、分娩和 PPH 处理方面无明显差异。两组患者在球囊取出后均未行侵入性手术。量化总失血量(BTIU ≤ 7 h:1126 mL (383) vs BTIU > 7 h:1240 mL (505),P = 0.1)或RGC输血量(BTIU ≤ 7 h:9 (18%) vs BTIU > 7 h:40 (27%),P = 0.2)无明显差异。在产后 6 周内,子宫内膜炎的发生率没有明显差异(BTIU ≤ 7 h:1(2%) vs BTUIgt & 7 h :2 (2%),p = 0.9)、出院时的母乳喂养率(BTIU ≤ 7 h:40 (78%) vs BTIU > 7 h:104 (70%),p = 0.3)和产后住院时间(BTIU ≤ 7 h:4 天 (4-5.5) vs BTIU > 7 h:4 天 (4-5),p = 0.5)。结论如果宫内填塞立即有效,则持续时间似乎会缩短。
{"title":"Peut-on réduire la durée du tamponnement intra-utérin par ballonnet ? Analyse secondaire d’un essai randomisé","authors":"C. Prats ,&nbsp;C. Garabedian ,&nbsp;P. Rozenberg ,&nbsp;P. Berveiller","doi":"10.1016/j.gofs.2024.03.051","DOIUrl":"https://doi.org/10.1016/j.gofs.2024.03.051","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Contexte&lt;/h3&gt;&lt;p&gt;Le recours au ballon de tamponnement intra-utérin (BTIU) dans la prise en charge de l’hémorragie du post-partum immédiate (HPPI), après échec des traitements utérotoniques, fait partie des algorithmes de prise en charge. Les facteurs prédictifs d’échec avant l’insertion du BTIU sont bien connus, de même que l’importance pronostique des premières minutes après la mise en place du ballon. Après contrôle de l’hémorragie par le BTIU, des questions subsistent quant à la durée appropriée de tamponnement par ballon.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Objectif&lt;/h3&gt;&lt;p&gt;Évaluer l’impact de la réduction de la durée du BTIU sur le risque de récidive de l’hémorragie.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Méthode&lt;/h3&gt;&lt;p&gt;Il s’agit d’une analyse secondaire non planifiée de l’essai multicentrique TUB (essai validé par le CPP de Poissy, consentement écrit des patientes), qui évaluait l’efficacité d’un BTIU précoce sur l’HPPI après un accouchement par voie vaginale. Dans notre étude, seules les femmes prises en charge par un BTIU ont été incluses. Les femmes dont le ballon a été retiré dans les deux premières heures suivant sa mise en place et les femmes ayant eu une procédure invasive avant le retrait du BTIU ont été exclues. Les critères de jugement ont été : la survenue d’une procédure invasive après le retrait du ballon, les pertes sanguines totales, les transfusions de culots globulaires, ainsi que l’endométrite du postpartum, l’allaitement à la sortie de l’hôpital et la durée du séjour à l’hôpital. Le premier quartile pour la durée totale du BTIU dans notre population étant de 6,9&lt;!--&gt; &lt;!--&gt;heures, les patientes qui ont eu un BTIU pendant ≤&lt;!--&gt; &lt;!--&gt;7&lt;!--&gt; &lt;!--&gt;heures ont été comparées à celles qui ont eu un BTIU pendant&lt;!--&gt; &lt;!--&gt;&gt;&lt;!--&gt; &lt;!--&gt;7&lt;!--&gt; &lt;!--&gt;heures.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Résultats&lt;/h3&gt;&lt;p&gt;199 patientes ont été incluses, dont 51 ont eu un BTIU pendant moins de 7&lt;!--&gt; &lt;!--&gt;heures. Il n’y avait pas de différence significative entre les deux groupes sur les caractéristiques maternelles, l’accouchement et la prise en charge de l’HPPI. Il n’y a eu aucun recours à une procédure invasive après le retrait du ballon dans les deux groupes. Il n’y avait pas de différence significative en ce qui concerne les pertes sanguines totales quantifiées (BTIU ≤ 7&lt;!--&gt; &lt;!--&gt;h : 1126&lt;!--&gt; &lt;!--&gt;mL (383) vs BTIU&lt;!--&gt; &lt;!--&gt;&gt;&lt;!--&gt; &lt;!--&gt;7&lt;!--&gt; &lt;!--&gt;h : 1240&lt;!--&gt; &lt;!--&gt;mL (505), &lt;em&gt;p&lt;/em&gt; &lt;!--&gt;=&lt;!--&gt; &lt;!--&gt;0,1) ou la transfusion de CGR (BTIU&lt;!--&gt; &lt;!--&gt;≤&lt;!--&gt; &lt;!--&gt;7&lt;!--&gt; &lt;!--&gt;h : 9 (18 %) vs BTIU&lt;!--&gt; &lt;!--&gt;&gt;&lt;!--&gt; &lt;!--&gt;7&lt;!--&gt; &lt;!--&gt;h : 40 (27 %), &lt;em&gt;p&lt;/em&gt; &lt;!--&gt;=&lt;!--&gt; &lt;!--&gt;0,2). Concernant le postpartum, aucune différence significative n’était observée sur la survenue d’une endométrite 6 semaines après l’accouchement (BTIU&lt;!--&gt; &lt;!--&gt;≤&lt;!--&gt; &lt;!--&gt;7&lt;!--&gt; &lt;!--&gt;h : 1 (2 %) vs BTUI&lt;!--&gt; &lt;!--&gt;&gt;&lt;!--&gt; &lt;!--&gt;7&lt;!--&gt; &lt;!--&gt;h : 2 (2 %), &lt;em&gt;p&lt;/em&gt; &lt;!--&gt;=&lt;!--&gt; &lt;!--&gt;0,9), l’allaitement à la sortie (BTIU ≤&lt;!--&gt; &lt;!--&gt;7&lt;!--&gt; &lt;!--&gt;h : 40 (78 %) vs BTIU&lt;!--&gt; &lt;!--&gt;&gt;&lt;!--&gt; &lt;!--&gt;7&lt;!--&gt; &lt;!--&gt;h : 104 (70 %),","PeriodicalId":56056,"journal":{"name":"Gynecologie Obstetrique Fertilite & Senologie","volume":"52 5","pages":"Page 364"},"PeriodicalIF":0.8,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140879161","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Gynecologie Obstetrique Fertilite & Senologie
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1